Medco said U.S. denied patent FDA approval is also lacking.
Medco said U.S. denied patent FDA FDA
abbr.
Food and Drug Administration
FDA,
n.pr See Food and Drug Administration.
FDA,
n.pr the abbreviation for the Food and Drug Administration. approval is also lacking
WEST LOS ANGELES - West Los Angeles, Los Angeles, California, a neighborhood of Los Angeles
- West Los Angeles (region), a popularly identified region of Los Angeles, incorporating the neighborhood above
-- Medco Research Inc., a publicly held medical
products research company, last week announced that it has been denied a
patent application for one if its key drugs, named Adenoscan Adenoscan® Cardiology A sterile formulation of adenosine used as an adjunct to thallium in cardiac imaging to evaluate CAD in Pts unable to adequately exercise and take the treadmill component of related tests. See Treadmill test. . "The
United States Patent and Trademark Office The United States Patent and Trademark Office (PTO or USPTO) is an agency in the United States Department of Commerce that provides patent protection to inventors and businesses for their inventions, and trademark registration for product and intellectual property that it has rejected an
application" to patent Adenoscan, said Medco.
Medco said it will appeal the ruling. The company also said it has
submitted the drug to the federal Food and Drug Administration for
approval, and has completed testing on the drug.
COPYRIGHT 1990 CBJ, L.P.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1990, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion